Skip to content

A Randomized Control Trial To Study The Effect Of Warm Footbath And Aromatherapy On The Level Of The Stress, Sleep Quality And Fatigue Among Patients With Cancer Undergoing Chemotherapy And Radiation Therapy In R.I.M.S. Ranchi

A randomized control trial to study the effect of warm footbath and aromatherapy on the level of the stress, sleep quality and fatigue among patients with cancer undergoing chemotherapy and radiation therapy in selected hospitals in Ranchi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091666
Enrollment
75
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C800- Disseminated malignant neoplasm, unspecified

Interventions

Intervention1: Warm Footbath and Lavender Aromatherapy: Warm Footbath: Explained the procedure to the patient and informed consent will be obtained. The patient was asked to sit in a comfortable pos

Sponsors

Rajendra Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cancer undergoing chemotherapy and radiation therapy who were admitted at R.I.M.S. , Ranchi. Patients who were willing to participate in this study. Both male and female patients. Patients who can speak and understand Hindi.

Exclusion criteria

Exclusion criteria: Patients who are unconscious. Patients who were receiving chemotherapy and radiation therapy and having other hereditary diseases like diabetic foot ulcers, paralysis of lower extremities. Patients who are terminally ill. Patients who are having mental illness.

Design outcomes

Primary

MeasureTime frame
The effectiveness of warm footbath and aromatherapy on the level of stress, sleep and fatigue among patients with cancer undergoing chemotherapy and radiation therapy in experimental group is greater than control group.Timepoint: Time points for the study will be baseline , 2 weeks and 4 weeks.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr. Arpita Rai

Rajendra Institute of Medical Sciences

kujurmamta2204@gmail.com9430102561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026